Global Paclitaxel Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Paclitaxel market size is predicted to grow from US$ 144 million in 2025 to US$ 236 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it 'taxol'.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
LP Information, Inc. (LPI) ' newest research report, the “Paclitaxel Industry Forecast” looks at past sales and reviews total world Paclitaxel sales in 2024, providing a comprehensive analysis by region and market sector of projected Paclitaxel sales for 2025 through 2031. With Paclitaxel sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel industry.
This Insight Report provides a comprehensive analysis of the global Paclitaxel landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paclitaxel market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Paclitaxel market?
What factors are driving Paclitaxel market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paclitaxel market opportunities vary by end market size?
How does Paclitaxel break out by Type, by Application?
The global Paclitaxel market size is predicted to grow from US$ 144 million in 2025 to US$ 236 million in 2031; it is expected to grow at a CAGR of 8.5% from 2025 to 2031.
Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it 'taxol'.
North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.
LP Information, Inc. (LPI) ' newest research report, the “Paclitaxel Industry Forecast” looks at past sales and reviews total world Paclitaxel sales in 2024, providing a comprehensive analysis by region and market sector of projected Paclitaxel sales for 2025 through 2031. With Paclitaxel sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel industry.
This Insight Report provides a comprehensive analysis of the global Paclitaxel landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Paclitaxel market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel.
This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Natural Paclitaxel API
- Semi-synthetic Paclitaxel API
- Ovarian Cancer
- Cervical Cancer
- Breast Cancer
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Phyton
- ScinoPharm
- Novasep
- Samyang
- Polymed
- TAPI (Teva)
- Fresenius-kabi
- Huiang biopharma
- Southpharma
- Yunnan Hande
- Hainan Yew Pharm
- Jiangsu Yew Biotechnology
What is the 10-year outlook for the global Paclitaxel market?
What factors are driving Paclitaxel market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Paclitaxel market opportunities vary by end market size?
How does Paclitaxel break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Paclitaxel Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Paclitaxel by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Paclitaxel by Country/Region, 2020, 2024 & 2031
2.2 Paclitaxel Segment by Type
2.2.1 Natural Paclitaxel API
2.2.2 Semi-synthetic Paclitaxel API
2.3 Paclitaxel Sales by Type
2.3.1 Global Paclitaxel Sales Market Share by Type (2020-2025)
2.3.2 Global Paclitaxel Revenue and Market Share by Type (2020-2025)
2.3.3 Global Paclitaxel Sale Price by Type (2020-2025)
2.4 Paclitaxel Segment by Application
2.4.1 Ovarian Cancer
2.4.2 Cervical Cancer
2.4.3 Breast Cancer
2.4.4 Others
2.5 Paclitaxel Sales by Application
2.5.1 Global Paclitaxel Sale Market Share by Application (2020-2025)
2.5.2 Global Paclitaxel Revenue and Market Share by Application (2020-2025)
2.5.3 Global Paclitaxel Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Paclitaxel Breakdown Data by Company
3.1.1 Global Paclitaxel Annual Sales by Company (2020-2025)
3.1.2 Global Paclitaxel Sales Market Share by Company (2020-2025)
3.2 Global Paclitaxel Annual Revenue by Company (2020-2025)
3.2.1 Global Paclitaxel Revenue by Company (2020-2025)
3.2.2 Global Paclitaxel Revenue Market Share by Company (2020-2025)
3.3 Global Paclitaxel Sale Price by Company
3.4 Key Manufacturers Paclitaxel Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel Product Location Distribution
3.4.2 Players Paclitaxel Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PACLITAXEL BY GEOGRAPHIC REGION
4.1 World Historic Paclitaxel Market Size by Geographic Region (2020-2025)
4.1.1 Global Paclitaxel Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Paclitaxel Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Paclitaxel Market Size by Country/Region (2020-2025)
4.2.1 Global Paclitaxel Annual Sales by Country/Region (2020-2025)
4.2.2 Global Paclitaxel Annual Revenue by Country/Region (2020-2025)
4.3 Americas Paclitaxel Sales Growth
4.4 APAC Paclitaxel Sales Growth
4.5 Europe Paclitaxel Sales Growth
4.6 Middle East & Africa Paclitaxel Sales Growth
5 AMERICAS
5.1 Americas Paclitaxel Sales by Country
5.1.1 Americas Paclitaxel Sales by Country (2020-2025)
5.1.2 Americas Paclitaxel Revenue by Country (2020-2025)
5.2 Americas Paclitaxel Sales by Type (2020-2025)
5.3 Americas Paclitaxel Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paclitaxel Sales by Region
6.1.1 APAC Paclitaxel Sales by Region (2020-2025)
6.1.2 APAC Paclitaxel Revenue by Region (2020-2025)
6.2 APAC Paclitaxel Sales by Type (2020-2025)
6.3 APAC Paclitaxel Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Paclitaxel by Country
7.1.1 Europe Paclitaxel Sales by Country (2020-2025)
7.1.2 Europe Paclitaxel Revenue by Country (2020-2025)
7.2 Europe Paclitaxel Sales by Type (2020-2025)
7.3 Europe Paclitaxel Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Paclitaxel by Country
8.1.1 Middle East & Africa Paclitaxel Sales by Country (2020-2025)
8.1.2 Middle East & Africa Paclitaxel Revenue by Country (2020-2025)
8.2 Middle East & Africa Paclitaxel Sales by Type (2020-2025)
8.3 Middle East & Africa Paclitaxel Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paclitaxel
10.3 Manufacturing Process Analysis of Paclitaxel
10.4 Industry Chain Structure of Paclitaxel
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paclitaxel Distributors
11.3 Paclitaxel Customer
12 WORLD FORECAST REVIEW FOR PACLITAXEL BY GEOGRAPHIC REGION
12.1 Global Paclitaxel Market Size Forecast by Region
12.1.1 Global Paclitaxel Forecast by Region (2026-2031)
12.1.2 Global Paclitaxel Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Paclitaxel Forecast by Type (2026-2031)
12.7 Global Paclitaxel Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Phyton
13.1.1 Phyton Company Information
13.1.2 Phyton Paclitaxel Product Portfolios and Specifications
13.1.3 Phyton Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Phyton Main Business Overview
13.1.5 Phyton Latest Developments
13.2 ScinoPharm
13.2.1 ScinoPharm Company Information
13.2.2 ScinoPharm Paclitaxel Product Portfolios and Specifications
13.2.3 ScinoPharm Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 ScinoPharm Main Business Overview
13.2.5 ScinoPharm Latest Developments
13.3 Novasep
13.3.1 Novasep Company Information
13.3.2 Novasep Paclitaxel Product Portfolios and Specifications
13.3.3 Novasep Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novasep Main Business Overview
13.3.5 Novasep Latest Developments
13.4 Samyang
13.4.1 Samyang Company Information
13.4.2 Samyang Paclitaxel Product Portfolios and Specifications
13.4.3 Samyang Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Samyang Main Business Overview
13.4.5 Samyang Latest Developments
13.5 Polymed
13.5.1 Polymed Company Information
13.5.2 Polymed Paclitaxel Product Portfolios and Specifications
13.5.3 Polymed Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Polymed Main Business Overview
13.5.5 Polymed Latest Developments
13.6 TAPI (Teva)
13.6.1 TAPI (Teva) Company Information
13.6.2 TAPI (Teva) Paclitaxel Product Portfolios and Specifications
13.6.3 TAPI (Teva) Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 TAPI (Teva) Main Business Overview
13.6.5 TAPI (Teva) Latest Developments
13.7 Fresenius-kabi
13.7.1 Fresenius-kabi Company Information
13.7.2 Fresenius-kabi Paclitaxel Product Portfolios and Specifications
13.7.3 Fresenius-kabi Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Fresenius-kabi Main Business Overview
13.7.5 Fresenius-kabi Latest Developments
13.8 Huiang biopharma
13.8.1 Huiang biopharma Company Information
13.8.2 Huiang biopharma Paclitaxel Product Portfolios and Specifications
13.8.3 Huiang biopharma Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Huiang biopharma Main Business Overview
13.8.5 Huiang biopharma Latest Developments
13.9 Southpharma
13.9.1 Southpharma Company Information
13.9.2 Southpharma Paclitaxel Product Portfolios and Specifications
13.9.3 Southpharma Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Southpharma Main Business Overview
13.9.5 Southpharma Latest Developments
13.10 Yunnan Hande
13.10.1 Yunnan Hande Company Information
13.10.2 Yunnan Hande Paclitaxel Product Portfolios and Specifications
13.10.3 Yunnan Hande Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yunnan Hande Main Business Overview
13.10.5 Yunnan Hande Latest Developments
13.11 Hainan Yew Pharm
13.11.1 Hainan Yew Pharm Company Information
13.11.2 Hainan Yew Pharm Paclitaxel Product Portfolios and Specifications
13.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hainan Yew Pharm Main Business Overview
13.11.5 Hainan Yew Pharm Latest Developments
13.12 Jiangsu Yew Biotechnology
13.12.1 Jiangsu Yew Biotechnology Company Information
13.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Portfolios and Specifications
13.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jiangsu Yew Biotechnology Main Business Overview
13.12.5 Jiangsu Yew Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Paclitaxel Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Paclitaxel by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Paclitaxel by Country/Region, 2020, 2024 & 2031
2.2 Paclitaxel Segment by Type
2.2.1 Natural Paclitaxel API
2.2.2 Semi-synthetic Paclitaxel API
2.3 Paclitaxel Sales by Type
2.3.1 Global Paclitaxel Sales Market Share by Type (2020-2025)
2.3.2 Global Paclitaxel Revenue and Market Share by Type (2020-2025)
2.3.3 Global Paclitaxel Sale Price by Type (2020-2025)
2.4 Paclitaxel Segment by Application
2.4.1 Ovarian Cancer
2.4.2 Cervical Cancer
2.4.3 Breast Cancer
2.4.4 Others
2.5 Paclitaxel Sales by Application
2.5.1 Global Paclitaxel Sale Market Share by Application (2020-2025)
2.5.2 Global Paclitaxel Revenue and Market Share by Application (2020-2025)
2.5.3 Global Paclitaxel Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Paclitaxel Breakdown Data by Company
3.1.1 Global Paclitaxel Annual Sales by Company (2020-2025)
3.1.2 Global Paclitaxel Sales Market Share by Company (2020-2025)
3.2 Global Paclitaxel Annual Revenue by Company (2020-2025)
3.2.1 Global Paclitaxel Revenue by Company (2020-2025)
3.2.2 Global Paclitaxel Revenue Market Share by Company (2020-2025)
3.3 Global Paclitaxel Sale Price by Company
3.4 Key Manufacturers Paclitaxel Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel Product Location Distribution
3.4.2 Players Paclitaxel Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR PACLITAXEL BY GEOGRAPHIC REGION
4.1 World Historic Paclitaxel Market Size by Geographic Region (2020-2025)
4.1.1 Global Paclitaxel Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Paclitaxel Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Paclitaxel Market Size by Country/Region (2020-2025)
4.2.1 Global Paclitaxel Annual Sales by Country/Region (2020-2025)
4.2.2 Global Paclitaxel Annual Revenue by Country/Region (2020-2025)
4.3 Americas Paclitaxel Sales Growth
4.4 APAC Paclitaxel Sales Growth
4.5 Europe Paclitaxel Sales Growth
4.6 Middle East & Africa Paclitaxel Sales Growth
5 AMERICAS
5.1 Americas Paclitaxel Sales by Country
5.1.1 Americas Paclitaxel Sales by Country (2020-2025)
5.1.2 Americas Paclitaxel Revenue by Country (2020-2025)
5.2 Americas Paclitaxel Sales by Type (2020-2025)
5.3 Americas Paclitaxel Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paclitaxel Sales by Region
6.1.1 APAC Paclitaxel Sales by Region (2020-2025)
6.1.2 APAC Paclitaxel Revenue by Region (2020-2025)
6.2 APAC Paclitaxel Sales by Type (2020-2025)
6.3 APAC Paclitaxel Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Paclitaxel by Country
7.1.1 Europe Paclitaxel Sales by Country (2020-2025)
7.1.2 Europe Paclitaxel Revenue by Country (2020-2025)
7.2 Europe Paclitaxel Sales by Type (2020-2025)
7.3 Europe Paclitaxel Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Paclitaxel by Country
8.1.1 Middle East & Africa Paclitaxel Sales by Country (2020-2025)
8.1.2 Middle East & Africa Paclitaxel Revenue by Country (2020-2025)
8.2 Middle East & Africa Paclitaxel Sales by Type (2020-2025)
8.3 Middle East & Africa Paclitaxel Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paclitaxel
10.3 Manufacturing Process Analysis of Paclitaxel
10.4 Industry Chain Structure of Paclitaxel
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paclitaxel Distributors
11.3 Paclitaxel Customer
12 WORLD FORECAST REVIEW FOR PACLITAXEL BY GEOGRAPHIC REGION
12.1 Global Paclitaxel Market Size Forecast by Region
12.1.1 Global Paclitaxel Forecast by Region (2026-2031)
12.1.2 Global Paclitaxel Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Paclitaxel Forecast by Type (2026-2031)
12.7 Global Paclitaxel Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Phyton
13.1.1 Phyton Company Information
13.1.2 Phyton Paclitaxel Product Portfolios and Specifications
13.1.3 Phyton Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Phyton Main Business Overview
13.1.5 Phyton Latest Developments
13.2 ScinoPharm
13.2.1 ScinoPharm Company Information
13.2.2 ScinoPharm Paclitaxel Product Portfolios and Specifications
13.2.3 ScinoPharm Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 ScinoPharm Main Business Overview
13.2.5 ScinoPharm Latest Developments
13.3 Novasep
13.3.1 Novasep Company Information
13.3.2 Novasep Paclitaxel Product Portfolios and Specifications
13.3.3 Novasep Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novasep Main Business Overview
13.3.5 Novasep Latest Developments
13.4 Samyang
13.4.1 Samyang Company Information
13.4.2 Samyang Paclitaxel Product Portfolios and Specifications
13.4.3 Samyang Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Samyang Main Business Overview
13.4.5 Samyang Latest Developments
13.5 Polymed
13.5.1 Polymed Company Information
13.5.2 Polymed Paclitaxel Product Portfolios and Specifications
13.5.3 Polymed Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Polymed Main Business Overview
13.5.5 Polymed Latest Developments
13.6 TAPI (Teva)
13.6.1 TAPI (Teva) Company Information
13.6.2 TAPI (Teva) Paclitaxel Product Portfolios and Specifications
13.6.3 TAPI (Teva) Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 TAPI (Teva) Main Business Overview
13.6.5 TAPI (Teva) Latest Developments
13.7 Fresenius-kabi
13.7.1 Fresenius-kabi Company Information
13.7.2 Fresenius-kabi Paclitaxel Product Portfolios and Specifications
13.7.3 Fresenius-kabi Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Fresenius-kabi Main Business Overview
13.7.5 Fresenius-kabi Latest Developments
13.8 Huiang biopharma
13.8.1 Huiang biopharma Company Information
13.8.2 Huiang biopharma Paclitaxel Product Portfolios and Specifications
13.8.3 Huiang biopharma Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Huiang biopharma Main Business Overview
13.8.5 Huiang biopharma Latest Developments
13.9 Southpharma
13.9.1 Southpharma Company Information
13.9.2 Southpharma Paclitaxel Product Portfolios and Specifications
13.9.3 Southpharma Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Southpharma Main Business Overview
13.9.5 Southpharma Latest Developments
13.10 Yunnan Hande
13.10.1 Yunnan Hande Company Information
13.10.2 Yunnan Hande Paclitaxel Product Portfolios and Specifications
13.10.3 Yunnan Hande Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Yunnan Hande Main Business Overview
13.10.5 Yunnan Hande Latest Developments
13.11 Hainan Yew Pharm
13.11.1 Hainan Yew Pharm Company Information
13.11.2 Hainan Yew Pharm Paclitaxel Product Portfolios and Specifications
13.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Hainan Yew Pharm Main Business Overview
13.11.5 Hainan Yew Pharm Latest Developments
13.12 Jiangsu Yew Biotechnology
13.12.1 Jiangsu Yew Biotechnology Company Information
13.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Portfolios and Specifications
13.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Jiangsu Yew Biotechnology Main Business Overview
13.12.5 Jiangsu Yew Biotechnology Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Paclitaxel Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Paclitaxel Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Natural Paclitaxel API
Table 4. Major Players of Semi-synthetic Paclitaxel API
Table 5. Global Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 6. Global Paclitaxel Sales Market Share by Type (2020-2025)
Table 7. Global Paclitaxel Revenue by Type (2020-2025) & ($ million)
Table 8. Global Paclitaxel Revenue Market Share by Type (2020-2025)
Table 9. Global Paclitaxel Sale Price by Type (2020-2025) & (USD/Kg)
Table 10. Global Paclitaxel Sale by Application (2020-2025) & (Kg)
Table 11. Global Paclitaxel Sale Market Share by Application (2020-2025)
Table 12. Global Paclitaxel Revenue by Application (2020-2025) & ($ million)
Table 13. Global Paclitaxel Revenue Market Share by Application (2020-2025)
Table 14. Global Paclitaxel Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Paclitaxel Sales by Company (2020-2025) & (Kg)
Table 16. Global Paclitaxel Sales Market Share by Company (2020-2025)
Table 17. Global Paclitaxel Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Paclitaxel Revenue Market Share by Company (2020-2025)
Table 19. Global Paclitaxel Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Paclitaxel Producing Area Distribution and Sales Area
Table 21. Players Paclitaxel Products Offered
Table 22. Paclitaxel Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Paclitaxel Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Paclitaxel Sales Market Share Geographic Region (2020-2025)
Table 27. Global Paclitaxel Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Paclitaxel Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Paclitaxel Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Paclitaxel Sales Market Share by Country/Region (2020-2025)
Table 31. Global Paclitaxel Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Paclitaxel Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Paclitaxel Sales by Country (2020-2025) & (Kg)
Table 34. Americas Paclitaxel Sales Market Share by Country (2020-2025)
Table 35. Americas Paclitaxel Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 37. Americas Paclitaxel Sales by Application (2020-2025) & (Kg)
Table 38. APAC Paclitaxel Sales by Region (2020-2025) & (Kg)
Table 39. APAC Paclitaxel Sales Market Share by Region (2020-2025)
Table 40. APAC Paclitaxel Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 42. APAC Paclitaxel Sales by Application (2020-2025) & (Kg)
Table 43. Europe Paclitaxel Sales by Country (2020-2025) & (Kg)
Table 44. Europe Paclitaxel Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 46. Europe Paclitaxel Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Paclitaxel Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Paclitaxel Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 50. Middle East & Africa Paclitaxel Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Paclitaxel
Table 52. Key Market Challenges & Risks of Paclitaxel
Table 53. Key Industry Trends of Paclitaxel
Table 54. Paclitaxel Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Paclitaxel Distributors List
Table 57. Paclitaxel Customer List
Table 58. Global Paclitaxel Sales Forecast by Region (2026-2031) & (Kg)
Table 59. Global Paclitaxel Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Paclitaxel Sales Forecast by Country (2026-2031) & (Kg)
Table 61. Americas Paclitaxel Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Paclitaxel Sales Forecast by Region (2026-2031) & (Kg)
Table 63. APAC Paclitaxel Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Paclitaxel Sales Forecast by Country (2026-2031) & (Kg)
Table 65. Europe Paclitaxel Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Paclitaxel Sales Forecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Paclitaxel Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Paclitaxel Sales Forecast by Type (2026-2031) & (Kg)
Table 69. Global Paclitaxel Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Paclitaxel Sales Forecast by Application (2026-2031) & (Kg)
Table 71. Global Paclitaxel Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Phyton Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 73. Phyton Paclitaxel Product Portfolios and Specifications
Table 74. Phyton Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Phyton Main Business
Table 76. Phyton Latest Developments
Table 77. ScinoPharm Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 78. ScinoPharm Paclitaxel Product Portfolios and Specifications
Table 79. ScinoPharm Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. ScinoPharm Main Business
Table 81. ScinoPharm Latest Developments
Table 82. Novasep Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 83. Novasep Paclitaxel Product Portfolios and Specifications
Table 84. Novasep Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Novasep Main Business
Table 86. Novasep Latest Developments
Table 87. Samyang Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 88. Samyang Paclitaxel Product Portfolios and Specifications
Table 89. Samyang Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Samyang Main Business
Table 91. Samyang Latest Developments
Table 92. Polymed Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 93. Polymed Paclitaxel Product Portfolios and Specifications
Table 94. Polymed Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Polymed Main Business
Table 96. Polymed Latest Developments
Table 97. TAPI (Teva) Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 98. TAPI (Teva) Paclitaxel Product Portfolios and Specifications
Table 99. TAPI (Teva) Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. TAPI (Teva) Main Business
Table 101. TAPI (Teva) Latest Developments
Table 102. Fresenius-kabi Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 103. Fresenius-kabi Paclitaxel Product Portfolios and Specifications
Table 104. Fresenius-kabi Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Fresenius-kabi Main Business
Table 106. Fresenius-kabi Latest Developments
Table 107. Huiang biopharma Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 108. Huiang biopharma Paclitaxel Product Portfolios and Specifications
Table 109. Huiang biopharma Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. Huiang biopharma Main Business
Table 111. Huiang biopharma Latest Developments
Table 112. Southpharma Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 113. Southpharma Paclitaxel Product Portfolios and Specifications
Table 114. Southpharma Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Southpharma Main Business
Table 116. Southpharma Latest Developments
Table 117. Yunnan Hande Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 118. Yunnan Hande Paclitaxel Product Portfolios and Specifications
Table 119. Yunnan Hande Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Yunnan Hande Main Business
Table 121. Yunnan Hande Latest Developments
Table 122. Hainan Yew Pharm Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 123. Hainan Yew Pharm Paclitaxel Product Portfolios and Specifications
Table 124. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Hainan Yew Pharm Main Business
Table 126. Hainan Yew Pharm Latest Developments
Table 127. Jiangsu Yew Biotechnology Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Yew Biotechnology Paclitaxel Product Portfolios and Specifications
Table 129. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Jiangsu Yew Biotechnology Main Business
Table 131. Jiangsu Yew Biotechnology Latest Developments
Table 1. Paclitaxel Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Paclitaxel Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Natural Paclitaxel API
Table 4. Major Players of Semi-synthetic Paclitaxel API
Table 5. Global Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 6. Global Paclitaxel Sales Market Share by Type (2020-2025)
Table 7. Global Paclitaxel Revenue by Type (2020-2025) & ($ million)
Table 8. Global Paclitaxel Revenue Market Share by Type (2020-2025)
Table 9. Global Paclitaxel Sale Price by Type (2020-2025) & (USD/Kg)
Table 10. Global Paclitaxel Sale by Application (2020-2025) & (Kg)
Table 11. Global Paclitaxel Sale Market Share by Application (2020-2025)
Table 12. Global Paclitaxel Revenue by Application (2020-2025) & ($ million)
Table 13. Global Paclitaxel Revenue Market Share by Application (2020-2025)
Table 14. Global Paclitaxel Sale Price by Application (2020-2025) & (USD/Kg)
Table 15. Global Paclitaxel Sales by Company (2020-2025) & (Kg)
Table 16. Global Paclitaxel Sales Market Share by Company (2020-2025)
Table 17. Global Paclitaxel Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Paclitaxel Revenue Market Share by Company (2020-2025)
Table 19. Global Paclitaxel Sale Price by Company (2020-2025) & (USD/Kg)
Table 20. Key Manufacturers Paclitaxel Producing Area Distribution and Sales Area
Table 21. Players Paclitaxel Products Offered
Table 22. Paclitaxel Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Paclitaxel Sales by Geographic Region (2020-2025) & (Kg)
Table 26. Global Paclitaxel Sales Market Share Geographic Region (2020-2025)
Table 27. Global Paclitaxel Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Paclitaxel Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Paclitaxel Sales by Country/Region (2020-2025) & (Kg)
Table 30. Global Paclitaxel Sales Market Share by Country/Region (2020-2025)
Table 31. Global Paclitaxel Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Paclitaxel Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Paclitaxel Sales by Country (2020-2025) & (Kg)
Table 34. Americas Paclitaxel Sales Market Share by Country (2020-2025)
Table 35. Americas Paclitaxel Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 37. Americas Paclitaxel Sales by Application (2020-2025) & (Kg)
Table 38. APAC Paclitaxel Sales by Region (2020-2025) & (Kg)
Table 39. APAC Paclitaxel Sales Market Share by Region (2020-2025)
Table 40. APAC Paclitaxel Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 42. APAC Paclitaxel Sales by Application (2020-2025) & (Kg)
Table 43. Europe Paclitaxel Sales by Country (2020-2025) & (Kg)
Table 44. Europe Paclitaxel Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 46. Europe Paclitaxel Sales by Application (2020-2025) & (Kg)
Table 47. Middle East & Africa Paclitaxel Sales by Country (2020-2025) & (Kg)
Table 48. Middle East & Africa Paclitaxel Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Paclitaxel Sales by Type (2020-2025) & (Kg)
Table 50. Middle East & Africa Paclitaxel Sales by Application (2020-2025) & (Kg)
Table 51. Key Market Drivers & Growth Opportunities of Paclitaxel
Table 52. Key Market Challenges & Risks of Paclitaxel
Table 53. Key Industry Trends of Paclitaxel
Table 54. Paclitaxel Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Paclitaxel Distributors List
Table 57. Paclitaxel Customer List
Table 58. Global Paclitaxel Sales Forecast by Region (2026-2031) & (Kg)
Table 59. Global Paclitaxel Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Paclitaxel Sales Forecast by Country (2026-2031) & (Kg)
Table 61. Americas Paclitaxel Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Paclitaxel Sales Forecast by Region (2026-2031) & (Kg)
Table 63. APAC Paclitaxel Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Paclitaxel Sales Forecast by Country (2026-2031) & (Kg)
Table 65. Europe Paclitaxel Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Paclitaxel Sales Forecast by Country (2026-2031) & (Kg)
Table 67. Middle East & Africa Paclitaxel Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Paclitaxel Sales Forecast by Type (2026-2031) & (Kg)
Table 69. Global Paclitaxel Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Paclitaxel Sales Forecast by Application (2026-2031) & (Kg)
Table 71. Global Paclitaxel Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Phyton Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 73. Phyton Paclitaxel Product Portfolios and Specifications
Table 74. Phyton Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Phyton Main Business
Table 76. Phyton Latest Developments
Table 77. ScinoPharm Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 78. ScinoPharm Paclitaxel Product Portfolios and Specifications
Table 79. ScinoPharm Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 80. ScinoPharm Main Business
Table 81. ScinoPharm Latest Developments
Table 82. Novasep Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 83. Novasep Paclitaxel Product Portfolios and Specifications
Table 84. Novasep Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 85. Novasep Main Business
Table 86. Novasep Latest Developments
Table 87. Samyang Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 88. Samyang Paclitaxel Product Portfolios and Specifications
Table 89. Samyang Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 90. Samyang Main Business
Table 91. Samyang Latest Developments
Table 92. Polymed Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 93. Polymed Paclitaxel Product Portfolios and Specifications
Table 94. Polymed Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 95. Polymed Main Business
Table 96. Polymed Latest Developments
Table 97. TAPI (Teva) Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 98. TAPI (Teva) Paclitaxel Product Portfolios and Specifications
Table 99. TAPI (Teva) Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 100. TAPI (Teva) Main Business
Table 101. TAPI (Teva) Latest Developments
Table 102. Fresenius-kabi Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 103. Fresenius-kabi Paclitaxel Product Portfolios and Specifications
Table 104. Fresenius-kabi Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 105. Fresenius-kabi Main Business
Table 106. Fresenius-kabi Latest Developments
Table 107. Huiang biopharma Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 108. Huiang biopharma Paclitaxel Product Portfolios and Specifications
Table 109. Huiang biopharma Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 110. Huiang biopharma Main Business
Table 111. Huiang biopharma Latest Developments
Table 112. Southpharma Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 113. Southpharma Paclitaxel Product Portfolios and Specifications
Table 114. Southpharma Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 115. Southpharma Main Business
Table 116. Southpharma Latest Developments
Table 117. Yunnan Hande Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 118. Yunnan Hande Paclitaxel Product Portfolios and Specifications
Table 119. Yunnan Hande Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 120. Yunnan Hande Main Business
Table 121. Yunnan Hande Latest Developments
Table 122. Hainan Yew Pharm Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 123. Hainan Yew Pharm Paclitaxel Product Portfolios and Specifications
Table 124. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 125. Hainan Yew Pharm Main Business
Table 126. Hainan Yew Pharm Latest Developments
Table 127. Jiangsu Yew Biotechnology Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Yew Biotechnology Paclitaxel Product Portfolios and Specifications
Table 129. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 130. Jiangsu Yew Biotechnology Main Business
Table 131. Jiangsu Yew Biotechnology Latest Developments
LIST OF FIGURES
Figure 1. Picture of Paclitaxel
Figure 2. Paclitaxel Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Paclitaxel Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Paclitaxel Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Paclitaxel Sales Market Share by Country/Region (2024)
Figure 10. Paclitaxel Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Natural Paclitaxel API
Figure 12. Product Picture of Semi-synthetic Paclitaxel API
Figure 13. Global Paclitaxel Sales Market Share by Type in 2025
Figure 14. Global Paclitaxel Revenue Market Share by Type (2020-2025)
Figure 15. Paclitaxel Consumed in Ovarian Cancer
Figure 16. Global Paclitaxel Market: Ovarian Cancer (2020-2025) & (Kg)
Figure 17. Paclitaxel Consumed in Cervical Cancer
Figure 18. Global Paclitaxel Market: Cervical Cancer (2020-2025) & (Kg)
Figure 19. Paclitaxel Consumed in Breast Cancer
Figure 20. Global Paclitaxel Market: Breast Cancer (2020-2025) & (Kg)
Figure 21. Paclitaxel Consumed in Others
Figure 22. Global Paclitaxel Market: Others (2020-2025) & (Kg)
Figure 23. Global Paclitaxel Sale Market Share by Application (2024)
Figure 24. Global Paclitaxel Revenue Market Share by Application in 2025
Figure 25. Paclitaxel Sales by Company in 2025 (Kg)
Figure 26. Global Paclitaxel Sales Market Share by Company in 2025
Figure 27. Paclitaxel Revenue by Company in 2025 ($ millions)
Figure 28. Global Paclitaxel Revenue Market Share by Company in 2025
Figure 29. Global Paclitaxel Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Paclitaxel Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Paclitaxel Sales 2020-2025 (Kg)
Figure 32. Americas Paclitaxel Revenue 2020-2025 ($ millions)
Figure 33. APAC Paclitaxel Sales 2020-2025 (Kg)
Figure 34. APAC Paclitaxel Revenue 2020-2025 ($ millions)
Figure 35. Europe Paclitaxel Sales 2020-2025 (Kg)
Figure 36. Europe Paclitaxel Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Paclitaxel Sales 2020-2025 (Kg)
Figure 38. Middle East & Africa Paclitaxel Revenue 2020-2025 ($ millions)
Figure 39. Americas Paclitaxel Sales Market Share by Country in 2025
Figure 40. Americas Paclitaxel Revenue Market Share by Country (2020-2025)
Figure 41. Americas Paclitaxel Sales Market Share by Type (2020-2025)
Figure 42. Americas Paclitaxel Sales Market Share by Application (2020-2025)
Figure 43. United States Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Paclitaxel Sales Market Share by Region in 2025
Figure 48. APAC Paclitaxel Revenue Market Share by Region (2020-2025)
Figure 49. APAC Paclitaxel Sales Market Share by Type (2020-2025)
Figure 50. APAC Paclitaxel Sales Market Share by Application (2020-2025)
Figure 51. China Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 55. India Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Paclitaxel Sales Market Share by Country in 2025
Figure 59. Europe Paclitaxel Revenue Market Share by Country (2020-2025)
Figure 60. Europe Paclitaxel Sales Market Share by Type (2020-2025)
Figure 61. Europe Paclitaxel Sales Market Share by Application (2020-2025)
Figure 62. Germany Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 63. France Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Paclitaxel Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Paclitaxel Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Paclitaxel Sales Market Share by Application (2020-2025)
Figure 70. Egypt Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Paclitaxel in 2025
Figure 76. Manufacturing Process Analysis of Paclitaxel
Figure 77. Industry Chain Structure of Paclitaxel
Figure 78. Channels of Distribution
Figure 79. Global Paclitaxel Sales Market Forecast by Region (2026-2031)
Figure 80. Global Paclitaxel Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Paclitaxel Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Paclitaxel Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Paclitaxel Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Paclitaxel Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Paclitaxel
Figure 2. Paclitaxel Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel Sales Growth Rate 2020-2031 (Kg)
Figure 7. Global Paclitaxel Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Paclitaxel Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Paclitaxel Sales Market Share by Country/Region (2024)
Figure 10. Paclitaxel Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Natural Paclitaxel API
Figure 12. Product Picture of Semi-synthetic Paclitaxel API
Figure 13. Global Paclitaxel Sales Market Share by Type in 2025
Figure 14. Global Paclitaxel Revenue Market Share by Type (2020-2025)
Figure 15. Paclitaxel Consumed in Ovarian Cancer
Figure 16. Global Paclitaxel Market: Ovarian Cancer (2020-2025) & (Kg)
Figure 17. Paclitaxel Consumed in Cervical Cancer
Figure 18. Global Paclitaxel Market: Cervical Cancer (2020-2025) & (Kg)
Figure 19. Paclitaxel Consumed in Breast Cancer
Figure 20. Global Paclitaxel Market: Breast Cancer (2020-2025) & (Kg)
Figure 21. Paclitaxel Consumed in Others
Figure 22. Global Paclitaxel Market: Others (2020-2025) & (Kg)
Figure 23. Global Paclitaxel Sale Market Share by Application (2024)
Figure 24. Global Paclitaxel Revenue Market Share by Application in 2025
Figure 25. Paclitaxel Sales by Company in 2025 (Kg)
Figure 26. Global Paclitaxel Sales Market Share by Company in 2025
Figure 27. Paclitaxel Revenue by Company in 2025 ($ millions)
Figure 28. Global Paclitaxel Revenue Market Share by Company in 2025
Figure 29. Global Paclitaxel Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Paclitaxel Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Paclitaxel Sales 2020-2025 (Kg)
Figure 32. Americas Paclitaxel Revenue 2020-2025 ($ millions)
Figure 33. APAC Paclitaxel Sales 2020-2025 (Kg)
Figure 34. APAC Paclitaxel Revenue 2020-2025 ($ millions)
Figure 35. Europe Paclitaxel Sales 2020-2025 (Kg)
Figure 36. Europe Paclitaxel Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Paclitaxel Sales 2020-2025 (Kg)
Figure 38. Middle East & Africa Paclitaxel Revenue 2020-2025 ($ millions)
Figure 39. Americas Paclitaxel Sales Market Share by Country in 2025
Figure 40. Americas Paclitaxel Revenue Market Share by Country (2020-2025)
Figure 41. Americas Paclitaxel Sales Market Share by Type (2020-2025)
Figure 42. Americas Paclitaxel Sales Market Share by Application (2020-2025)
Figure 43. United States Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Paclitaxel Sales Market Share by Region in 2025
Figure 48. APAC Paclitaxel Revenue Market Share by Region (2020-2025)
Figure 49. APAC Paclitaxel Sales Market Share by Type (2020-2025)
Figure 50. APAC Paclitaxel Sales Market Share by Application (2020-2025)
Figure 51. China Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 55. India Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 57. China Taiwan Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Paclitaxel Sales Market Share by Country in 2025
Figure 59. Europe Paclitaxel Revenue Market Share by Country (2020-2025)
Figure 60. Europe Paclitaxel Sales Market Share by Type (2020-2025)
Figure 61. Europe Paclitaxel Sales Market Share by Application (2020-2025)
Figure 62. Germany Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 63. France Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Paclitaxel Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Paclitaxel Sales Market Share by Type (2020-2025)
Figure 69. Middle East & Africa Paclitaxel Sales Market Share by Application (2020-2025)
Figure 70. Egypt Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 73. Turkey Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Paclitaxel Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Paclitaxel in 2025
Figure 76. Manufacturing Process Analysis of Paclitaxel
Figure 77. Industry Chain Structure of Paclitaxel
Figure 78. Channels of Distribution
Figure 79. Global Paclitaxel Sales Market Forecast by Region (2026-2031)
Figure 80. Global Paclitaxel Revenue Market Share Forecast by Region (2026-2031)
Figure 81. Global Paclitaxel Sales Market Share Forecast by Type (2026-2031)
Figure 82. Global Paclitaxel Revenue Market Share Forecast by Type (2026-2031)
Figure 83. Global Paclitaxel Sales Market Share Forecast by Application (2026-2031)
Figure 84. Global Paclitaxel Revenue Market Share Forecast by Application (2026-2031)
More Publications
Global Tetrabenazine Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
December 2025
92 pages
Global Therapeutic BCG Vaccines Market Growth 2025-2031
US$ 3,660.00
December 2025
89 pages
Global Radiotherapy Motion Management Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
September 2025
97 pages
Global DNA Vaccines Market Growth 2025-2031
US$ 3,660.00
January 2025
101 pages
